It has been discovered that the RAS-MAPK molecular pathway is hyper-activated in NS patients, and consequently several genes involved in its regulation have a role in the onset of NS, such as PTPN11, SOS1, RAF1, etc. [2,4,5,6]. This evidence concerns the gene PTPN11 and Netherton syndrome.